Featured Stories
-
Clinical trial awareness and access amongst culturally and linguistically diverse (CALD) populations: environmental scan
ACTA has created an environmental scan of national and international initiatives seeking to increase participation in clinical trials by people from culturally and linguistically diverse (CALD) backgrounds.
-
COVID-19
We’ve created this area for COVID-19 information relevant to clinical trials. In line with the national guidance and emphasis on the safety and well-being of patients, research participants and their families, and health care professionals, researchers and other staff involved in patient care and research, ACTA strongly supports the continuation of investigator-led trials, where it is safe to do so, and with due consideration to any protocol amendments appropriate for the current COVID-19 pandemic.
-
Activities critical to success and growth of Clinical Trials Networks: Sector consultation
Senior Clinical Trial Networks members and Executive Officers identified key activities critical to the success and sustainability of CTN, and to identify unmet needs.